Xr Securities LLC Novavax Inc Call Options Transaction History

Xr Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 02, 2023	BUY	$5.76 - $12.48 $82,368 - $178,464	14,300 New	14,300 $99,000
Q1 2022 Apr 14, 2022	SELL	$69.73 - $142.9 $878,598 - $1.8 Million	-12,600 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$134.56 - $217.97 $376,768 - $610,316	2,800 Added 28.57%	12,600 $101,000
Q3 2021 Oct 14, 2021	BUY	$177.8 - $270.58 $568,960 - $865,856	3,200 Added 48.48%	9,800 $277,000
Q2 2021 Jul 26, 2021	BUY	$121.0 - $257.67 $798,600 - $1.7 Million	6,600 New	6,600 $276,000

286

84.7M

5.38M

8.62M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.